Cargando…

Preventing treatment delays for benign gynaecological conditions

Detalles Bibliográficos
Autor principal:	Robinson, Dudley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Invited Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450483/ https://www.ncbi.nlm.nih.gov/pubmed/36092376 http://dx.doi.org/10.1016/j.crwh.2022.e00448

Ejemplares similares

Delay in managing benign gynaecological conditions in women of reproductive age during the COVID-19 pandemic in low-and middle-income countries
por: Ngene, Nnabuike Chibuoke, et al.
Publicado: (2021)

Language and medicine: Breaking the barriers in gynaecological cancer
por: Brennan, Donal J.
Publicado: (2021)

Vaginal mesh: What lessons have we learnt?
por: Robinson, Dudley, et al.
Publicado: (2020)

Fertility preservation in women with benign gynaecological conditions
por: Santulli, Pietro, et al.
Publicado: (2023)

Current treatment of benign biliary strictures
por: Costamagna, Guido, et al.
Publicado: (2013)

Childhood adversity and gynecological conditions
por: Kapoor, Ekta
Publicado: (2022)

Post-COVID-19 condition and pregnancy
por: Machado, Keshini, et al.
Publicado: (2022)

Biodegradable esophageal stents for the treatment of refractory benign esophageal strictures
por: Gkolfakis, Paraskevas, et al.
Publicado: (2020)

Placenta accreta spectrum - the ongoing evolution of an iatrogenic condition
por: Bartels, Helena C., et al.
Publicado: (2023)

Role of Rezum in the treatment of benign prostate hyperplasia: A review of the literature
por: Cocci, Andrea, et al.
Publicado: (2021)

Isaria cicadae conidia possess antiproliferative and inducing apoptosis properties in gynaecological carcinoma cells
por: Sun, Yan-fang, et al.
Publicado: (2017)

Case reports: Advancing knowledge of rare or unusual medical conditions
por: Ngene, Nnabuike Chibuoke, et al.
Publicado: (2022)

Multiple enzyme studies in the vaginal fluid in relation to benign and malignant gynaecological conditions.
por: Muir, G. G.
Publicado: (1966)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Prevention of cardiovascular disease: are we successful?( )
por: De Backer, Guy
Publicado: (2022)

Menopause and personal protective equipment: How does this meet acceptable working conditions?
por: Kydd, Angela
Publicado: (2021)

Primary stroke prevention in China – a new approach
por: Feigin, Valery L., et al.
Publicado: (2015)

Gynæcological Antiseptics
por: Dudley, E. C.
Publicado: (1887)

Rare Benign Tumors of the Liver: Still Rare?
por: Bertino, Gaetano, et al.
Publicado: (2014)

The Gynæcological Fad
Publicado: (1895)

Developing an operational research model for strengthening policy and programs on prevention and control of hypertension in India
por: Goel, Sonu
Publicado: (2022)

Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia
por: De Nunzio, Cosimo, et al.
Publicado: (2020)

Editorial: mesalazine to prevent recurrent acute diverticulitis—the final nail in the coffin. Authors’ reply
por: Kruis, W., et al.
Publicado: (2017)

Preventing the Next Pandemic: The Case for Investing in Circulatory Health – A Global Coalition for Circulatory Health Position Paper
por: Ferat, Leslie Rae, et al.
Publicado: (2021)

Body image concerns in individuals diagnosed with benign gynaecological conditions: scoping review and meta-synthesis
por: Sayer-Jones, Katherine, et al.
Publicado: (2021)

The Chicago Gynæcological Society
Publicado: (1879)

Lean NAFLD: A not so benign condition?
por: VanWagner, Lisa B., et al.
Publicado: (2018)

Genetics of pubertal delay
por: Saengkaew, Tansit, et al.
Publicado: (2021)

Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy
por: Fontana, Marianna, et al.
Publicado: (2023)

Maintaining Efficacy But Decreasing Toxicity in the Treatment of Hodgkin Lymphoma
por: Ansell, Stephen M.
Publicado: (2017)

Non‐ossifying fibroma: A RAS‐MAPK driven benign bone neoplasm
por: Bovée, Judith VMG, et al.
Publicado: (2019)

What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)?
por: Foo, Keong Tatt
Publicado: (2019)

Local Massage in the Treatment of Certain Gynæcological Conditions
por: Marshall, G. Balfour
Publicado: (1895)

Metabolically Healthy Obesity: Is It Really a Benign Condition?
por: Kim, Hwi Seung, et al.
Publicado: (2021)

Transactions of the American Gynæcological Society
Publicado: (1877)

Bronchopleural fistula treatment: From the archetype of surgery to the future of stem cell therapy
por: Petrella, Francesco, et al.
Publicado: (2015)

Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia?
por: Rastrelli, Giulia, et al.
Publicado: (2019)

The metastatic castration-resistant prostate cancer treatment paradigm: more choices, more questions
por: Yu, Evan Y, et al.
Publicado: (2014)

Delayed Cerebral Ischemia: Is Prevention Better Than Treatment?
por: Koenig, Heidi M., et al.
Publicado: (2021)

Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies?
por: De Angelis, Carlo
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_m9jflf8tolkrmant44ohfhtgr6